Rothschild Investment LLC’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.7K Buy
1,353
+1,081
+397% +$10.4K ﹤0.01% 1552
2026
Q1
$2.02K Sell
272
-33
-11% -$347 ﹤0.01% 2560
2025
Q4
$3.59K Buy
305
+15
+5% +$162 ﹤0.01% 2060
2025
Q3
$2.24K Buy
290
+115
+66% +$806 ﹤0.01% 2159
2025
Q2
$1.28K Buy
175
+65
+59% +$525 ﹤0.01% 2330
2025
Q1
$1.04K Sell
110
-45
-29% -$562 ﹤0.01% 2316
2024
Q4
$2.55K Buy
155
+35
+29% +$544 ﹤0.01% 1655
2024
Q3
$1.77K Buy
120
+90
+300% +$1.41K ﹤0.01% 1794
2024
Q2
$416 Buy
30
+20
+200% +$284 ﹤0.01% 2132
2024
Q1
$157 Buy
+10
New +$154 ﹤0.01% 1876

Other funds holding NEO

Rothschild Investment LLC's NEO Position: Q2 2026 in Review

Rothschild Investment LLC increased its NeoGenomics (NEO) stake by 397% in Q2 2026, buying an estimated $10.4K and bringing the position to 1,353 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

Rothschild Investment LLC first reported a position in NEO in Q1 2024 and has held it in 10 quarters since. 95 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Rothschild Investment LLC held 1,353 shares of NeoGenomics worth $19.7K as of Q2 2026.
  • Rothschild Investment LLC bought 1,081 NeoGenomics shares in Q2 2026, an estimated $10.4K.
  • NeoGenomics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1552 holding.
  • Rothschild Investment LLC first reported a position in NeoGenomics in Q1 2024 and has held it in 10 quarters since.
  • 95 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.